Female Health Company board member to serve as observer on Veru Healthcare post merger
CHICAGO - The Female Health Company and Aspen Park Pharmaceuticals on Tuesday announced that, upon completion of their proposed merger, Andy Love will serve as an observer to the board of directors of the combined company.
Love is a current member of FHC's board of directors.
While he serves as a board observer, Love will participate in board meetings of the merged company, to be called Veru Healthcare.
“We welcome Andy to the Veru Healthcare Board,” stated Mitchell Steiner, CEO and president of APP and the combined company, Veru Healthcare, after completion of the proposed merger. “His insights and experience strongly complement the skill set and expertise of the Veru Healthcare board.”
“Andy is an enthusiastic supporter of the merger, having recently purchased shares of FHC stock to add to his already sizable ownership position,” added O.B. Parrish, chairman and CEO of FHC. “He has been a valuable member of the FHC Board and important link to members of the investment community. His status as observer will greatly increase our ability to continue to effectively communicate with our shareholders.”
Love has served as a director of FHC since May 2013. He served as chairman and co-CEO of Love Savings Holding Company, the holding company of Heartland Bank, from December 1985 to December 2014.
Currently, he is chairman and co-CEO of Hallmark Investment Corporation, successor to the non-banking activities of Love Savings Holding Company subsequent to its merger with Midland States Bancorp on Dec. 31, 2014.
Love has more than 40 years of investment, banking and real estate experience. Previously, Love was a partner at the law firm Bryan Cave.
As previously announced, the Veru Healthcare board of directors will be comprised of nine members, with three directors named by FHC (O.B. Parrish, David Bethune and Mary Margaret Frank), three directors currently on APP’s board of directors (Mitchell Steiner, Harry Fisch and Elgar Peerschke, who will serve as chairman) and three new directors (Georges Makhoul, Lucy Lu and Mario Eisenberger).